A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor
A strategy is described for the re-design of DNA damaging platinum(II) complexes to afford elevated toxicity towards cancer cells expressing the estrogen receptor (ER). Two platinum-based toxicants are described in which a DNA damaging warhead, [Pt(en)Cl[subscript 2]] (en, ethylenediamine), is tethe...
Main Authors: | Kim, Eunsuk, Rye, Peter T., Essigmann, John M., Croy, Robert G. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Center for Environmental Health Sciences |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2015
|
Online Access: | http://hdl.handle.net/1721.1/99185 https://orcid.org/0000-0002-2196-5691 |
Similar Items
-
Novel genotoxins that target estrogen receptor- and androgen receptor- positive cancers : identification of DNA adducts, pharmacokinetics, and mechanism
by: Hillier, Shawn M. (Shawn Matthew)
Published: (2006) -
A new platinum anticancer drug forms a highly stereoselective adduct with duplex DNA
by: Chen, Y, et al.
Published: (1999) -
X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct
by: Zhu, Guangyu, et al.
Published: (2013) -
Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents
by: Chin, Chee Fei, et al.
Published: (2015) -
Mechanistic investigation of anticancer agents that damage DNA and interact with the estrogen receptor
by: Gopal, Sreeja
Published: (2011)